Phenotypeca is honoured to appoint Patrick Florent to non-Executive Chairman of the Board of Phenotypeca.

September 2020

We are delighted to announce Patrick Florent’s appointment to strengthen Phenotypeca’s Board of Directors.  Patrick has most recently been Head of Global Strategic Partnership at GSK Vaccines and Managing Director of their Belgian operations.

Commenting on his appointment, Keith Williams, Managing Director of Phenotypeca said ‘I have known Patrick for several decades, and I have been highly impressed by his clear thinking, understanding of how to communicate effectively to very different stakeholders, and proven strategic awareness; this will add significant skill and expertise to our Board.  By using our large libraries (over 1 billion strains) of Baker’s yeast as a starting point, we aim to and significantly reduce the cost of goods for vaccines for lower and middle income countries (LMIC’s). This is one of our strategic activities, and Patrick has vast experience and an excellent network in the vaccine space’.